Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the...
As the UK’s medical cannabis industry continues to come under fierce scrutiny from the country’s mainstream media, James Duckenfield, CEO...
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis...
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public....
After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis...
Glass Pharms, the UK-based cultivator of medical cannabis flower, has announced a supply agreement with Integro Clinic & IPS Pharmacy...
The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering...
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step...
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential,...
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall...
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in...
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and...
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025...
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of...
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and...
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads. Does it choose the pharmaceutically...
